Report cover image

Global Point of Care Molecular Diagnostics Market, 2025-2033

Publisher PreciseView Reports
Published Oct 11, 2025
Length 404 Pages
SKU # PCSR20630876

Description

Global Point-of-Care Molecular Diagnostics Market, valued at USD 4.8 billion in 2024, is projected to reach USD 11.2 billion by 2033, registering a CAGR of 9.8% during the 2025-2033 forecast period. This robust expansion is driven by the escalating prevalence of infectious and chronic diseases surpassing millions of cases annually, the push for decentralized rapid testing in resource-limited settings, and innovations in portable RT-PCR and INAAT platforms enhancing sensitivity and speed at a 10% annual rate. The sector has accelerated since 2023, bolstered by telemedicine synergies and post-pandemic preparedness for respiratory threats, with compact analyzers witnessing a 10% CAGR in Europe. Prominent patterns include the ascendancy of assays and kits for user-friendly deployment, RT-PCR's precision in respiratory applications, and hospitals & ICUs leading end-uses for critical interventions. Compelling prospects encompass AI-enhanced diagnostics in Asia Pacific's emerging hubs like India for affordable INAAT in research institutes, North American app-connected analyzers for cancer and hepatitis screenings, and European expansions in gastrointestinal testing amid aging demographics. Nonetheless, barriers such as elevated device costs, protracted regulatory approvals, and training gaps for non-lab environments continue to hinder accessibility in regions like Latin America. North America maintains over 35% share, anchored by the United States' R&D infrastructure, while Asia Pacific surges fastest at 10.5% CAGR, propelled by healthcare access gains in China and India.

Refined classifications support strategic navigation across product types, technologies, applications, sample types, end-uses, and regions. Product types prioritize assays & kits for convenience, technologies favor RT-PCR for accuracy, applications emphasize respiratory diseases for urgency, and end-uses highlight hospitals & ICUs for intensive care, with zonal traits-Asia Pacific for dynamism, North America for innovation, and Europe for compliance-focused growth.

Market Segmentation:


By Product Type:

Assays & Kits
Instruments & Analyzers
Software & Services

By Technology:

RT-PCR
INAAT
Other Technologies

By Application:

Respiratory Diseases
Sexually Transmitted Diseases
Hospital-acquired Infections
Cancer
Hepatitis
Gastrointestinal Disorders
Other Applications

By Sample Type:

Blood, Serum & Plasma
Urine
Other Sample Types

By End-Use:

Hospitals & ICUs
Physicians’ Offices
Diagnostic Laboratories
Research Institutes
Other End Users

By Region:

North America (United States, Canada, Others)
Europe (United Kingdom, Germany, France, Italy, Spain, Others)
Asia Pacific (China, Japan, India, South Korea, Australia, Others)
Latin America (Brazil, Others)
Middle East & Africa (United Arab Emirates, Others)

Please note:Delivery Timeline: 2-3 Business Days

Table of Contents

404 Pages
Research Objective
MARKET SEGMENTATION
Scope of the Study
Key Questions Answered in the Report
Chapter 1 Research Methodology
1.1 Research Objective
1.2 Market Research Process
1.2.1 Data Procurement and Data Mining
1.2.2 Data Analysis and Standardization
1.2.3 Data Processing and Market Formulation
1.2.4 Data Validation
1.3 Market Research Approach
1.3.1 Residential Research
1.3.2 Commercial Research
1.3.3 Assumptions & Limitations
1.4 Year Considered for the Study
Chapter 2 Executive Summary
2.1 Global Point of Care Molecular Diagnostics Market Snapshot
2.2 Global Point of Care Molecular Diagnostics Market
Chapter 3 Market Variables and Scope
3.1 Introduction to Point of Care Molecular Diagnostics
3.2 Classification and Scope
Chapter 4 Market Dynamics and Trends
4.1 Global Point of Care Molecular Diagnostics Market Dynamics
4.2 Global Point of Care Molecular Diagnostics Market Dynamics, Impact Analysis
4.3 Market Drivers
4.3.1 Driver 1
4.3.2 Driver 2
4.4 Market Restraints
4.4.1 Restraint 1
4.4.2 Restraint 2
4.5 Market Opportunity
4.5.1 Opportunity 1
4.5.2 Opportunity 2
Chapter 5 Premium Insights
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of Substitute Types
5.1.4 Rivalry among Existing Firms
5.1.5 Threat of New Entrants
5.2 Supply Chain Analysis
5.3 Market Share Analysis of Key Players, 2024
5.4 Market Entry Strategy Assessment
5.5 Strategic Recommendation for Stakeholders
Chapter 6 Global Point of Care Molecular Diagnostics Market, By Product Type
6.1 Global Point of Care Molecular Diagnostics Market, By Product Type, 2025 - 2033
6.2 Assays & Kits
6.3 Instruments & Analyzers
6.4 Software & Services
Chapter 7 Global Point of Care Molecular Diagnostics Market, By Technology
7.1 Global Point of Care Molecular Diagnostics Market, By Technology, 2025 - 2033
7.2 RT-PCR
7.3 INAAT
7.4 Other Technologies
Chapter 8 Global Point of Care Molecular Diagnostics Market, By Application
8.1 Global Point of Care Molecular Diagnostics Market, By Application, 2025 - 2033
8.2 Respiratory Diseases
8.3 Sexually Transmitted Diseases
8.4 Hospital-acquired Infections
8.5 Cancer
8.6 Hepatitis
8.7 Gastrointestinal Disorders
8.8 Other Applications
Chapter 9 Global Point of Care Molecular Diagnostics Market, By Sample Type
9.1 Global Point of Care Molecular Diagnostics Market, By Sample Type, 2025 - 2033
9.2 Blood, Serum & Plasma
9.3 Urine
9.4 Other Sample Types
Chapter 10 Global Point of Care Molecular Diagnostics Market, By End-Use
10.1 Global Point of Care Molecular Diagnostics Market, By End-Use, 2025 - 2033
10.2 Hospitals & ICUs
10.3 Physicians’ Offices
10.4 Diagnostic Laboratories
10.5 Research Institutes
10.6 Other End Users
Chapter 11 Global Point of Care Molecular Diagnostics Market, By Region
11.1 Overview
11.2 North America
11.2.1 North America Point of Care Molecular Diagnostics Market, By Country
11.2.2 North America Point of Care Molecular Diagnostics Market, By Product Type
11.2.3 North America Point of Care Molecular Diagnostics Market, By Technology
11.2.4 North America Point of Care Molecular Diagnostics Market, By Application
11.2.5 North America Point of Care Molecular Diagnostics Market, By Sample Type
11.2.6 North America Point of Care Molecular Diagnostics Market, By End-Use
11.2.7 United States
11.2.7.1 United States Point of Care Molecular Diagnostics Market, By Product Type
11.2.7.2 United States Point of Care Molecular Diagnostics Market, By Technology
11.2.7.3 United States Point of Care Molecular Diagnostics Market, By Application
11.2.7.4 United States Point of Care Molecular Diagnostics Market, By Sample Type
11.2.7.5 United States Point of Care Molecular Diagnostics Market, By End-Use
11.2.8 Canada
11.2.8.1 Canada Point of Care Molecular Diagnostics Market, By Product Type
11.2.8.2 Canada Point of Care Molecular Diagnostics Market, By Technology
11.2.8.3 Canada Point of Care Molecular Diagnostics Market, By Application
11.2.8.4 Canada Point of Care Molecular Diagnostics Market, By Sample Type
11.2.8.5 Canada Point of Care Molecular Diagnostics Market, By End-Use
11.2.9 Others
11.2.9.1 Others Point of Care Molecular Diagnostics Market, By Product Type
11.2.9.2 Others Point of Care Molecular Diagnostics Market, By Technology
11.2.9.3 Others Point of Care Molecular Diagnostics Market, By Application
11.2.9.4 Others Point of Care Molecular Diagnostics Market, By Sample Type
11.2.9.5 Others Point of Care Molecular Diagnostics Market, By End-Use
11.3 Europe
11.3.1 Europe Point of Care Molecular Diagnostics Market, By Country
11.3.2 Europe Point of Care Molecular Diagnostics Market, By Product Type
11.3.3 Europe Point of Care Molecular Diagnostics Market, By Technology
11.3.4 Europe Point of Care Molecular Diagnostics Market, By Application
11.3.5 Europe Point of Care Molecular Diagnostics Market, By Sample Type
11.3.6 Europe Point of Care Molecular Diagnostics Market, By End-Use
11.3.7 United Kingdom
11.3.7.1 United Kingdom Point of Care Molecular Diagnostics Market, By Product Type
11.3.7.2 United Kingdom Point of Care Molecular Diagnostics Market, By Technology
11.3.7.3 United Kingdom Point of Care Molecular Diagnostics Market, By Application
11.3.7.4 United Kingdom Point of Care Molecular Diagnostics Market, By Sample Type
11.3.7.5 United Kingdom Point of Care Molecular Diagnostics Market, By End-Use
11.3.8 Germany
11.3.8.1 Germany Point of Care Molecular Diagnostics Market, By Product Type
11.3.8.2 Germany Point of Care Molecular Diagnostics Market, By Technology
11.3.8.3 Germany Point of Care Molecular Diagnostics Market, By Application
11.3.8.4 Germany Point of Care Molecular Diagnostics Market, By Sample Type
11.3.8.5 Germany Point of Care Molecular Diagnostics Market, By End-Use
11.3.9 France
11.3.9.1 France Point of Care Molecular Diagnostics Market, By Product Type
11.3.9.2 France Point of Care Molecular Diagnostics Market, By Technology
11.3.9.3 France Point of Care Molecular Diagnostics Market, By Application
11.3.9.4 France Point of Care Molecular Diagnostics Market, By Sample Type
11.3.9.5 France Point of Care Molecular Diagnostics Market, By End-Use
11.3.10 Italy
11.3.10.1 Italy Point of Care Molecular Diagnostics Market, By Product Type
11.3.10.2 Italy Point of Care Molecular Diagnostics Market, By Technology
11.3.10.3 Italy Point of Care Molecular Diagnostics Market, By Application
11.3.10.4 Italy Point of Care Molecular Diagnostics Market, By Sample Type
11.3.10.5 Italy Point of Care Molecular Diagnostics Market, By End-Use
11.3.11 Spain
11.3.11.1 Spain Point of Care Molecular Diagnostics Market, By Product Type
11.3.11.2 Spain Point of Care Molecular Diagnostics Market, By Technology
11.3.11.3 Spain Point of Care Molecular Diagnostics Market, By Application
11.3.11.4 Spain Point of Care Molecular Diagnostics Market, By Sample Type
11.3.11.5 Spain Point of Care Molecular Diagnostics Market, By End-Use
11.3.12 Others
11.3.12.1 Others Point of Care Molecular Diagnostics Market, By Product Type
11.3.12.2 Others Point of Care Molecular Diagnostics Market, By Technology
11.3.12.3 Others Point of Care Molecular Diagnostics Market, By Application
11.3.12.4 Others Point of Care Molecular Diagnostics Market, By Sample Type
11.3.12.5 Others Point of Care Molecular Diagnostics Market, By End-Use
11.4 Asia Pacific
11.4.1 Asia Pacific Point of Care Molecular Diagnostics Market, By Country
11.4.2 Asia Pacific Point of Care Molecular Diagnostics Market, By Product Type
11.4.3 Asia Pacific Point of Care Molecular Diagnostics Market, By Technology
11.4.4 Asia Pacific Point of Care Molecular Diagnostics Market, By Application
11.4.5 Asia Pacific Point of Care Molecular Diagnostics Market, By Sample Type
11.4.6 Asia Pacific Point of Care Molecular Diagnostics Market, By End-Use
11.4.7 China
11.4.7.1 China Point of Care Molecular Diagnostics Market, By Product Type
11.4.7.2 China Point of Care Molecular Diagnostics Market, By Technology
11.4.7.3 China Point of Care Molecular Diagnostics Market, By Application
11.4.7.4 China Point of Care Molecular Diagnostics Market, By Sample Type
11.4.7.5 China Point of Care Molecular Diagnostics Market, By End-Use
11.4.8 Japan
11.4.8.1 Japan Point of Care Molecular Diagnostics Market, By Product Type
11.4.8.2 Japan Point of Care Molecular Diagnostics Market, By Technology
11.4.8.3 Japan Point of Care Molecular Diagnostics Market, By Application
11.4.8.4 Japan Point of Care Molecular Diagnostics Market, By Sample Type
11.4.8.5 Japan Point of Care Molecular Diagnostics Market, By End-Use
11.4.9 India
11.4.9.1 India Point of Care Molecular Diagnostics Market, By Product Type
11.4.9.2 India Point of Care Molecular Diagnostics Market, By Technology
11.4.9.3 India Point of Care Molecular Diagnostics Market, By Application
11.4.9.4 India Point of Care Molecular Diagnostics Market, By Sample Type
11.4.9.5 India Point of Care Molecular Diagnostics Market, By End-Use
11.4.10 South Korea
11.4.10.1 South Korea Point of Care Molecular Diagnostics Market, By Product Type
11.4.10.2 South Korea Point of Care Molecular Diagnostics Market, By Technology
11.4.10.3 South Korea Point of Care Molecular Diagnostics Market, By Application
11.4.10.4 South Korea Point of Care Molecular Diagnostics Market, By Sample Type
11.4.10.5 South Korea Point of Care Molecular Diagnostics Market, By End-Use
11.4.11 Australia
11.4.11.1 Australia Point of Care Molecular Diagnostics Market, By Product Type
11.4.11.2 Australia Point of Care Molecular Diagnostics Market, By Technology
11.4.11.3 Australia Point of Care Molecular Diagnostics Market, By Application
11.4.11.4 Australia Point of Care Molecular Diagnostics Market, By Sample Type
11.4.11.5 Australia Point of Care Molecular Diagnostics Market, By End-Use
11.4.12 Others
11.4.12.1 Others Point of Care Molecular Diagnostics Market, By Product Type
11.4.12.2 Others Point of Care Molecular Diagnostics Market, By Technology
11.4.12.3 Others Point of Care Molecular Diagnostics Market, By Application
11.4.12.4 Others Point of Care Molecular Diagnostics Market, By Sample Type
11.4.12.5 Others Point of Care Molecular Diagnostics Market, By End-Use
11.5 Latin America
11.5.1 Latin America Point of Care Molecular Diagnostics Market, By Country
11.5.2 Latin America Point of Care Molecular Diagnostics Market, By Product Type
11.5.3 Latin America Point of Care Molecular Diagnostics Market, By Technology
11.5.4 Latin America Point of Care Molecular Diagnostics Market, By Application
11.5.5 Latin America Point of Care Molecular Diagnostics Market, By Sample Type
11.5.6 Latin America Point of Care Molecular Diagnostics Market, By End-Use
11.5.7 Brazil
11.5.7.1 Brazil Point of Care Molecular Diagnostics Market, By Product Type
11.5.7.2 Brazil Point of Care Molecular Diagnostics Market, By Technology
11.5.7.3 Brazil Point of Care Molecular Diagnostics Market, By Application
11.5.7.4 Brazil Point of Care Molecular Diagnostics Market, By Sample Type
11.5.7.5 Brazil Point of Care Molecular Diagnostics Market, By End-Use
11.5.8 Others
11.5.8.1 Others Point of Care Molecular Diagnostics Market, By Product Type
11.5.8.2 Others Point of Care Molecular Diagnostics Market, By Technology
11.5.8.3 Others Point of Care Molecular Diagnostics Market, By Application
11.5.8.4 Others Point of Care Molecular Diagnostics Market, By Sample Type
11.5.8.5 Others Point of Care Molecular Diagnostics Market, By End-Use
11.6 Middle East and Africa (MEA)
11.6.1 Middle East and Africa (MEA) Point of Care Molecular Diagnostics Market, By Country
11.6.2 Middle East and Africa (MEA) Point of Care Molecular Diagnostics Market, By Product Type
11.6.3 Middle East and Africa (MEA) Point of Care Molecular Diagnostics Market, By Technology
11.6.4 Middle East and Africa (MEA) Point of Care Molecular Diagnostics Market, By Application
11.6.5 Middle East and Africa (MEA) Point of Care Molecular Diagnostics Market, By Sample Type
11.6.6 Middle East and Africa (MEA) Point of Care Molecular Diagnostics Market, By End-Use
11.6.7 United Arab Emirates
11.6.7.1 United Arab Emirates Point of Care Molecular Diagnostics Market, By Product Type
11.6.7.2 United Arab Emirates Point of Care Molecular Diagnostics Market, By Technology
11.6.7.3 United Arab Emirates Point of Care Molecular Diagnostics Market, By Application
11.6.7.4 United Arab Emirates Point of Care Molecular Diagnostics Market, By Sample Type
11.6.7.5 United Arab Emirates Point of Care Molecular Diagnostics Market, By End-Use
11.6.8 Others
11.6.8.1 Others Point of Care Molecular Diagnostics Market, By Product Type
11.6.8.2 Others Point of Care Molecular Diagnostics Market, By Technology
11.6.8.3 Others Point of Care Molecular Diagnostics Market, By Application
11.6.8.4 Others Point of Care Molecular Diagnostics Market, By Sample Type
11.6.8.5 Others Point of Care Molecular Diagnostics Market, By End-Use
Chapter 12 Competitive Landscape
12.1 Strategic Move Analysis
12.1.1 Top Player Positioning/Market Share Analysis
12.1.2 Top Winning Strategies, By Year, 2021-2024
12.1.3 Competitive Analysis by Revenue, 2022-2024
12.2 Recent Developments by the Market Participants (2024-25)
Chapter 13 Company Profiles
13.1 Abbott Laboratories
13.1.1 Company Snapshot
13.1.2 Company Overview
13.1.3 Financial Performance
13.1.4 Product Portfolio
13.1.5 Strategic Growth
13.2 F. Hoffmann-La Roche Ltd.
13.2.1 Company Snapshot
13.2.2 Company Overview
13.2.3 Financial Performance
13.2.4 Product Portfolio
13.2.5 Strategic Growth
13.3 bioMérieux SA
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Performance
13.3.4 Product Portfolio
13.3.5 Strategic Growth
13.4 Becton, Dickinson and Company
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Performance
13.4.4 Product Portfolio
13.4.5 Strategic Growth
13.5 Cepheid (Danaher Corporation)
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Financial Performance
13.5.4 Product Portfolio
13.5.5 Strategic Growth
13.6 Quidel Corporation
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Financial Performance
13.6.4 Product Portfolio
13.6.5 Strategic Growth
13.7 Bio-Rad Laboratories Inc.
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Financial Performance
13.7.4 Product Portfolio
13.7.5 Strategic Growth
13.8 Siemens Healthineers AG
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Financial Performance
13.8.4 Product Portfolio
13.8.5 Strategic Growth
13.9 Thermo Fisher Scientific Inc.
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Financial Performance
13.9.4 Product Portfolio
13.9.5 Strategic Growth
13.10 OraSure Technologies Inc.
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Financial Performance
13.10.4 Product Portfolio
13.10.5 Strategic Growth
13.11 iHealth Labs Inc.
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Financial Performance
13.11.4 Product Portfolio
13.11.5 Strategic Growth
13.12 Lucira Health Inc.
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Financial Performance
13.12.4 Product Portfolio
13.12.5 Strategic Growth
13.13 Cue Health Inc.
13.13.1 Company Snapshot
13.13.2 Company Overview
13.13.3 Financial Performance
13.13.4 Product Portfolio
13.13.5 Strategic Growth
13.14 Hologic Inc.
13.14.1 Company Snapshot
13.14.2 Company Overview
13.14.3 Financial Performance
13.14.4 Product Portfolio
13.14.5 Strategic Growth
13.15 LumiraDx Ltd.
13.15.1 Company Snapshot
13.15.2 Company Overview
13.15.3 Financial Performance
13.15.4 Product Portfolio
13.15.5 Strategic Growth

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us